Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neuroscience ; 446: 124-136, 2020 10 15.
Artigo em Inglês | MEDLINE | ID: mdl-32858142

RESUMO

Glutamine is an astroglia-derived precursor of the neurotransmitter glutamate, and its astroglia-to-neuron transfer is controlled by distinct glutamine transporters on the astrocytic and neuronal sites. In this study, we focused on the role of astrocytic glutamine efflux-mediating system N transporter SN1 in the maintenance of glutamatergic neurotransmission by analyzing the electrophysiological parameters ex vivo in the brain slices from control mice and mice in which vivo-morpholino technique was used to diminish SN1 protein. The glutamatergic transmission was characterized by electrophysiological recordings, ultrastructure of neuron terminals, and determination of proteins related to glutamate synaptic transmission: synaptophysin, synaptotagmin, and vit1A. The space-restricted ∼51,5% reduction of SN1 protein did not affect the expression of the neuronal glutamine transporter SAT2. SN1 depletion resulted in a reduction of field potentials (FPs), unaltered frequency of spontaneous and miniature excitatory postsynaptic currents (sEPSCs/mEPSCs), and presented a tendency towards a decrease of long-term potentiation (LTP). Ultrastructurally, preserved number of synaptic vesicles, primarily localized centrally of the cell body, correlates with unchanged levels of synaptic proteins. Collectively, the study indicates that glutamatergic transmission proceeds relatively independently of the SN1 - mediated glutamine transfer to the synapse.


Assuntos
Sistemas de Transporte de Aminoácidos Neutros , Sistemas de Transporte de Aminoácidos Neutros/metabolismo , Animais , Lobo Frontal/metabolismo , Ácido Glutâmico , Glutamina , Camundongos , Transmissão Sináptica
2.
Dermatology ; 193(3): 253-4, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8944352

RESUMO

A patient with psoriasis was found to have a large skin tumor on his scrotum. He had received psoralen and ultraviolet A radiation therapy to control psoriasis. Histopathologic study revealed that the tumor was a well-differentiated squamous cell carcinoma. We present this rare case and suggest that the genitalia be shielded during ultraviolet therapy.


Assuntos
Carcinoma de Células Escamosas/induzido quimicamente , Neoplasias dos Genitais Masculinos/induzido quimicamente , Terapia PUVA/efeitos adversos , Escroto/patologia , Neoplasias Cutâneas/induzido quimicamente , Idoso , Carcinoma de Células Escamosas/patologia , Neoplasias dos Genitais Masculinos/patologia , Humanos , Masculino , Psoríase/tratamento farmacológico , Doses de Radiação , Proteção Radiológica , Neoplasias Cutâneas/patologia , Raios Ultravioleta/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA